Pharmaceutical Executive September 22, 2025
Nicholas Jacobus

Rob DeWig, VP of Healthcare Sales at Inmar, touches on how access to 25% of benchmarking data from national pharmacy claims change for Premier Members.

Pharmaceutical Executive: How does access to 25% of benchmarking data from national pharmacy claims change for Premier members?
Rob DeWig: The insights that we can bring you know healthcare and really the world is full of data. And so how data without Insights is kind of cheap. And so byhaving the, 25% if you think about, if you take out some of those really big chains, that’s about 25% so just saying that the insights that we can pull from that and efficiencies, that we can bring to help recoup those dollars is critical. And you...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Interview / Q&A, Pharma, Pharma / Biotech, Trends
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation

Share Article